QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Related Article All Versions of this Article: mol.107.042077v1 72/6/1402    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Related articles in MolPharm Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dubyak, G. R. Search for Related Content PubMed PubMed Citation Articles by Dubyak, G. R.

Perspective

Go It Alone No More—P2X7 Joins the Society of Heteromeric ATP-Gated Receptor Channels

Department of Physiology and Biophysics, Case Western Reserve University School of Medicine, Cleveland, Ohio

P2X receptors (P2XR) function as ATP-gated nonselective ion channels permeable to Na⁺, K⁺, and Ca²⁺, and they are expressed in a wide range of excitable, epithelial/endothelial, and immune effector cell types. The channels are trimeric complexes composed of protein subunits encoded by seven different P2XR genes expressed in mammalian and other vertebrate genomes. Current genetic, biochemical, and/or physiological evidence indicates that the extended family of functional P2X receptors includes six homomeric channels composed of P2X1, P2X2, P2X3, P2X4, P2X5, or P2X7 subunits and six heteromeric channels that involve subunit pairings of P2X1/P2X2, P2X1/P2X4, P2X1/P2X5, P2X2/P2X3, P2X2/P2X6, or P2X4/P2X6. Thus, all P2XR subtypes—with the salient exception of P2X7R— have previously been implicated in the assembly of heteromeric ATP-gated ion channels that can comprise unique pharmacological targets in different tissues. The assumed "go-it alone" function of the P2X7R has important implications because agents that target this particular receptor have been proposed as useful therapeutics in various autoinflammatory diseases or amelioration of inflammatory pain. However, this assumption and the interpretations based on it now require reevaluation in light of a new report in this issue of Molecular Pharmacology (p. 1447) that provides convincing biochemical and electrophysiological evidence for the existence of P2X4/P2X7 heteromeric receptors.

Address correspondence to: George R. Dubyak, Department of Physiology and Biophysics, Case Western Reserve University, School of Medicine, Cleveland, OH 44106. E-mail: george.dubyak{at}case.edu

Related articles in MolPharm:

Evidence for Functional P2X₄/P2X₇ Heteromeric Receptors

Chang Guo, Marianela Masin, Omar S. Qureshi, and Ruth D. Murrell-Lagnado
MolPharm 2007 72: 1447-1456. [Abstract] [Full Text]  

This article has been cited by other articles:

				D. Donnelly-Roberts, S. McGaraughty, C.-C. Shieh, P. Honore, and M. F. Jarvis Painful Purinergic Receptors J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 409 - 415. [Abstract] [Full Text] [PDF]